GE HealthCare Q2 revenue up 5.7% to $5.3B; EPS $1.24; reaffirms FY guidance

GE HealthCare Technologies Inc.

Revenue $5.3B (+5.7% YoY); organic revenue +3.5%; net income $561M vs $486M.
Diluted EPS $1.24 (+16.5%); adjusted EPS $1.13 (+6.6%).
Record organic orders growth 11.1%, book-to-bill 1.15x, backlog $23.9B.
Patient Care Solutions revenue -13.3%, EBIT -$26M; CEO reviewing strategic options.
Reaffirms FY2026 guidance: organic rev growth 3-4%, adj EPS $4.80-$5.00, FCF ~$1.6B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.